Refine by
Metastasis Articles & Analysis
33 news found
Key presentations on Bayer research to be presented at AACR 2023 are listed below: Oral presentation: BAY 2965501: A highly selective DGKzeta inhibitor for cancer immuno-therapy with first-in-class potential Abstract ND04, Session DDT001 – New Drugs on the Horizon: Part 1 Sunday, April 16, 2:05 PM – 2:20 PM (EDT), Tangerine Ballroom 2 (WF2) - Convention Center Poster ...
ByBayer AG
“Many patients with rising PSA levels following surgery or radiation are at an increased risk of developing metastasis. With ARASTEP, we are optimistic about the potential to help patients at this earlier stage of the disease,” said Tara Frenkl, M.D., Senior Vice President and Head of Oncology Development at Bayer. ...
ByBayer AG
Additionally, cancer cells can be responsive to host-derived cytokines, i.e., inducing cancer cell proliferation, attenuating apoptosis, and promoting cellular invasion and metastasis, etc. The release of cytokines is stimulated by a variety of cellular stress responses, including carcinogen-induced injury, infection, and inflammation. ...
Based on the success of preclinical studies we suggest that 100% vs 3% of stroke patients will become treatable, ~90% of metastasis of cancers may be prevented and transfusion medicine practices will be 100% transformed globally. ...
High-risk disease was defined using the LATITUDE criteria, which includes ≥2 risk factors: a Gleason score of ≥8, ≥3 bone lesions, and the presence of measurable visceral metastasis. Of 1,305 patients in the full analysis set, 1,005 (77%) had high-volume disease, 912 (70%) had high-risk disease, 300 (23%) had low-volume disease, and 393 (30%) had low-risk disease. ...
ByBayer AG
Surgnova was glad to support the FIRST IRE procedures in Croatia with Dophi™ N3000 Electroporation System for patients with liver metastasis! Dophi N3000 Electroporation System is designed for tumor ablation with advanced precision, safety and reliability. ...
Thus, metabolomics is used to detect metabolic changes and responses so as to determine drug resistance within tumor cells and monitor related at early stages, including research on the multidrug resistance mechanisms and invasive metastasis of tumors. 3. Frequently analyzed pathways include: the protein synthesis pathway, the cysteine synthesis pathway, the glutamine ...
Lewis developed a real-time metastatic imaging model, researched the genetic mechanisms of cancer metastasis, and discovered promising anti-metastatic targets for use as gene therapies, and novel cancer biomarkers for use in biofluid diagnostics. ...
The paper also found that inhibition of this function of PAD4 reduces primary tumor growth and metastasis and enhances checkpoint inhibitor treatments. Jubilant Therapeutics Inc. is developing a novel small molecule PAD4 inhibitor that directly targets this mechanism. ...
The study population in the dose escalation phase will include patients with stable brain metastasis whose disease has failed prior standard therapy. Expansion cohorts will include patients with active brain metastases and high-grade gliomas. ...
Congratulations to investigators at Hannover School of Medicine and Heidelberg University Hospital for receiving the 2022 SNMMI Image of the Year Award and JNM Editors’ Choice Award for Overall Best Article in 2021, respectively. Both use FAPI as the primary indicator and further underscore its potential impact as a novel radiopharmaceutical. Each year, SNMMI chooses an image that best ...
BySOFIE
Cytokines play an important role in physiological and pathological processes such as immune cell differentiation and subset development, immune regulation, inflammatory response, and tumor metastasis. It can also mediate intercellular interactions and participate in tissue repair. ...
Cellular kinase assays showed narazaciclib’s highest inhibitory activity to be against CDK4/6, CSF1R, (supports pro-tumor immune suppression), and NUAK1/ARK 5 (associated with poor prognosis in multiple cancers and implicated in cancer cell migration, invasion, and metastasis). Cellular Thermal Shift Assay (CETSA) and integrative Inferred Kinase Activity (INKA) analysis ...
Crown Bioscience, a JSR Life Sciences company, and HUB Organoids (HUB) announced today the publication of preclinical data in the journal, Nature Cancer, on a bispecific antibody which prevents the onset of metastasis and slows the growth of primary tumors in experimental models of cancer. ...
Ghizlane Touimi Benjelloun of CHU de Nîmes, France on cryoablation of adrenal gland and vertebral metastasis. Scientific Presentation: Cryoablation of Low-Risk Breast Cancer An Update of the ICE3 Trial Dr. ...
The Merlin Test identifies melanoma patients that have a low risk for nodal metastasis and therefore can safely forgo a sentinel lymph node biopsy (SLNB) surgery. ...
In addition, nuclear gene mutations in conjunction with some transcription factors, e.g., PI3K-AKT, MAPK, STAT3, and signaling pathways affecting mitochondrial function cannot be ignored in the progression and metastasis of cancer as well. Given the significance of mitochondria in apoptosis, Creative Biogene provides rapid mitochondrial function testing services, allowing ...
PAD4 activity in tumor cells may play a significant role in cancer metastasis. The first-in-class mechanism of PAD4 inhibition reduces neutrophil extra-cellular traps (NETs) which stimulates cancer cell adhesion, migration and invasion. Therefore, inhibition of PAD4 could be a novel strategy to inhibit cancer progression and metastasis. Jubilant Therapeutics ...
PHILADELPHIA, March 08, 2022 (GLOBE NEWSWIRE) -- Context Therapeutics Inc. (“Context” or the “Company”) (Nasdaq: CNTX), a women’s oncology company developing small molecule and immunotherapy treatments for breast and gynecological cancers, today announced that five abstracts have been selected for poster or symposium presentations at the American Association for ...
Up to 90 % of solid tumors are hypoxic, which can contribute to multi-modal treatment resistance, increased risk of metastasis, and decreased survival. The fields of tumor hypoxia imaging and diagnostics are advancing quickly along with the ability to personalize treatment regimens to enhance radio/chemo/immuno-therapy in hypoxic areas. ...
ByCervoMed